Evaluation of Wound Drainage After Knee or Hip Arthroplasty
Status:
Withdrawn
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
To compare side effects and complications relating to use of warfarin or rivaroxaban,
tolerance and/or toxicity of these two agents such as drop in hemoglobin post operatively,
extent of bruising, quantity of wound drainage, duration of drainage, wound swelling, sub and
supra-therapeutic prothrombin times, need for transfusion, and patient tolerance in two
randomized groups. Return visits to the operating room, length of stay, and VTE rates will
also be compared.